GetTopicDetailResponse(id=83f91e173f8, topicName=Tazemetostat, introduction=Tazemetostat, content=null, image=null, comments=3, allHits=897, url=https://h5.medsci.cn/topic?id=17173, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=72966, tagList=[TagDto(tagId=72966, tagName=Tazemetostat)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1622021, encodeId=f0251622021bd, content=<a href='/topic/show?id=83f91e173f8' target=_blank style='color:#2F92EE;'>#Tazemetostat#</a>, objectTitle=TAZVERIK（tazemetostat）治療濾泡性淋巴瘤：FDA已批準其NDA, objectType=article, longId=188196, objectId=741e188196b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=741e188196b9, replyNumber=0, likeNumber=98, createdTime=2020-02-17, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=741e188196b9, moduleTitle=TAZVERIK（tazemetostat）治療濾泡性淋巴瘤：FDA已批準其NDA, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=741e188196b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622020, encodeId=75861622020f7, content=<a href='/topic/show?id=83f91e173f8' target=_blank style='color:#2F92EE;'>#Tazemetostat#</a>, objectTitle=TAZVERIK（Tazemetostat）已獲批準用于治療上皮樣肉瘤, objectType=article, longId=186735, objectId=a745186e35dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a745186e35dc, replyNumber=0, likeNumber=83, createdTime=2020-01-27, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a745186e35dc, moduleTitle=TAZVERIK（Tazemetostat）已獲批準用于治療上皮樣肉瘤, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a745186e35dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1622019, encodeId=9c361622019c6, content=<a href='/topic/show?id=83f91e173f8' target=_blank style='color:#2F92EE;'>#Tazemetostat#</a>, objectTitle=Lancet oncol：Tazemetostat，EZH2抑制劑，用于B細胞非霍奇金淋巴瘤和晚期固體腫瘤治療效率良好，且安全性良好, objectType=article, longId=134756, objectId=8eb0134e56d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8eb0134e56d7, replyNumber=0, likeNumber=58, createdTime=2018-04-12, rootId=0, userName=爆笑小醫(yī), userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8eb0134e56d7, moduleTitle=Lancet oncol：Tazemetostat，EZH2抑制劑，用于B細胞非霍奇金淋巴瘤和晚期固體腫瘤治療效率良好，且安全性良好, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8eb0134e56d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
